Depomed Inc (DEPO)

12.15
NASDAQ : Health Care
Prev Close 12.15
Day Low/High 0.00 / 0.00
52 Wk Low/High 11.34 / 27.02
Avg Volume 1.61M
Exchange NASDAQ
Shares Outstanding 62.10M
Market Cap 765.69M
EPS -1.40
P/E Ratio N/A
Div & Yield N.A. (N.A)

Latest News

Depomed Enters Oversold Territory (DEPO)

Depomed Enters Oversold Territory (DEPO)

Legendary investor Warren Buffett advises to be fearful when others are greedy, and be greedy when others are fearful. One way we can try to measure the level of fear in a given stock is through a technical analysis indicator called the Relative Strength Index, or RSI, which measures momentum on a scale of zero to 100.

DepoMed, Opioid Makers Fall After Trump's FDA Pick Says America's Drug Addiction Is Out of Control

DepoMed, Opioid Makers Fall After Trump's FDA Pick Says America's Drug Addiction Is Out of Control

Washington needs to do more, Gottlieb says at his confirmation hearing.

Biotech Premarket Movers: Sage Therapeutics, Depomed, NantKwest

Biotech Premarket Movers: Sage Therapeutics, Depomed, NantKwest

Sage Therapeutics, Depomed and NantKwest were among the biotech stock movers in premarket trading on Friday.

Depomed is Now Oversold (DEPO)

Depomed is Now Oversold (DEPO)

Legendary investor Warren Buffett advises to be fearful when others are greedy, and be greedy when others are fearful. One way we can try to measure the level of fear in a given stock is through a technical analysis indicator called the Relative Strength Index, or RSI, which measures momentum on a scale of zero to 100.

Biotech Premarket Movers: Vertex, Sangamo, Depomed

Biotech Premarket Movers: Vertex, Sangamo, Depomed

Vertex Pharmaceuticals, Sangamo Therapeutics and Depomed were among the biotech stock movers in premarket trading on Wednesday.

Depomed Switches Out CEO and Board in Making Peace With Activist Starboard

Depomed Switches Out CEO and Board in Making Peace With Activist Starboard

Depomed settles with activist investor Starboard and replaces its CEO and two board members.

Senator McCaskill Launching Investigation Into Opioid Drugmakers

Senator McCaskill Launching Investigation Into Opioid Drugmakers

The U.S. Centers for Disease Control and Prevention says 91 Americans die every day as a result of an overdose.

CFO Says Depomed to Buy or Be Sold

CFO Says Depomed to Buy or Be Sold

The biotech company will either pick up assets to grow or sell itself to a larger company in the space, its chief financial officer told a conference.

First Week Of May 19th Options Trading For Depomed (DEPO)

First Week Of May 19th Options Trading For Depomed (DEPO)

Investors in Depomed Inc saw new options begin trading this week, for the May 19th expiration. At Stock Options Channel, our YieldBoost formula has looked up and down the DEPO options chain for the new May 19th contracts and identified one put and one call contract of particular interest.

First Week of April 21st Options Trading For Depomed (DEPO)

First Week of April 21st Options Trading For Depomed (DEPO)

Investors in Depomed Inc saw new options become available this week, for the April 21st expiration. At Stock Options Channel, our YieldBoost formula has looked up and down the DEPO options chain for the new April 21st contracts and identified one put and one call contract of particular interest.

Argos Plummets 72%, Leads Biotech Movers

Argos Plummets 72%, Leads Biotech Movers

Also falling was Global Blood Therapeutics.

Depomed Reports 33% Increase in 2016 Net Product Sales

Depomed Reports 33% Increase in 2016 Net Product Sales

While companies in the opiod sector have had to deal with headlines about abuse as well as pharma pricing controversies, Depomed reported increased sales across its product line.

Board Revised as Perrigo Settles With Activist Investor Starboard

Board Revised as Perrigo Settles With Activist Investor Starboard

Starboard CEO Jeff Smith and two others are joining the board. The activist investor will also recommend two additional directors.

Biotech Stock Mailbag: Trump, Aurinia, Immunomedics, Cellceutix

Biotech Stock Mailbag: Trump, Aurinia, Immunomedics, Cellceutix

TheStreet's Adam Feuerstein answers readers' questions about biotech stocks.

Notable Thursday Option Activity: DEPO, OCN, X

Notable Thursday Option Activity: DEPO, OCN, X

Looking at options trading activity among components of the Russell 3000 index, there is noteworthy activity today in Depomed Inc , where a total volume of 8,605 contracts has been traded thus far today, a contract volume which is representative of approximately 860,500 underlying shares (given that every 1 contract represents 100 underlying shares). That number works out to 47.6% of DEPO's average daily trading volume over the past month, of 1.8 million shares.

Dow's March to 20,000 Hits Another Snag as Crude Settles at Two-Week Low

Dow's March to 20,000 Hits Another Snag as Crude Settles at Two-Week Low

The Dow Jones Industrial Average's march to 20,000 hit another roadblock on the first trading day of the year as crude oil prices reversed course.

Dow's Attempt at 20,000 Fades as Crude Reverses Course

Dow's Attempt at 20,000 Fades as Crude Reverses Course

The Dow Jones Industrial Average's march to 20,000 proves a challenge in the new year as stocks more than halve earlier gains by Tuesday afternoon.

Stocks Ease Off Highs as Dow 20,000 Remains a Challenge

Stocks Ease Off Highs as Dow 20,000 Remains a Challenge

Stocks ease back from session highs, though remain in the green Tuesday morning, as the Dow's march to 20,000 proves a challenge in the new year.

Stock Futures Rise Ahead of First Trading Day of 2017

Stock Futures Rise Ahead of First Trading Day of 2017

Stock futures move higher Tuesday morning ahead of the first trading day of the new year.

First Week Of February 2017 Options Trading For Depomed (DEPO)

First Week Of February 2017 Options Trading For Depomed (DEPO)

Investors in Depomed Inc saw new options become available this week, for the February 2017 expiration. At Stock Options Channel, our YieldBoost formula has looked up and down the DEPO options chain for the new February 2017 contracts and identified one put and one call contract of particular interest.

Ranking the Activists for Proxy Season 2016

Ranking the Activists for Proxy Season 2016

We recount the successes and failures of the biggest names in the activism game.